OptimizeRx Enters Retail Pharmacies, Supporting Adherence by Bringing Prescription Savings Directly to Patients via Higi Smar...
20 August 2020 - 2:00PM
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital
health solutions for life science companies, providers and
patients, has partnered with Higi, a consumer healthcare technology
and engagement company, giving healthcare consumers direct access
to savings and life sciences patient engagement programs. The
partnership introduces the OptimizeRx digital health platform
directly to healthcare consumers for the first time.
Higi users at 10,000 retail and pharmacy locations in major
chains nationwide will gain first-hand access to patient assistance
from life sciences organizations through OptimizeRx’s platform,
supporting adherence through both cost reduction measures and
educational content. Messaging highlighting savings and support
resources available through OptimizeRx will be displayed throughout
the Higi Station experience, both at the station itself and via
email to Higi’s engaged digital userbase.
The OptimizeRx platform delivers offers for savings on nearly
all prescribed medications, as well as life-sciences-sponsored
treatment support programs – two particularly pertinent needs for
consumers, as recent reports indicate record loss of
employer-sponsored health insurance due to the on-going COVID-19
economic impact.
Higi’s free-to-use FDA-cleared Smart Health Stations and
companion mobile app are designed to empower individuals to take
charge of their health through regular screening, simple tracking,
and delivery of curated health content from Higi and their
partners. Stations are located within leading food, drug, and club
stores to provide convenient access to consumers when managing
their health is top-of-mind.
“Our users want help being proactive about their health,” said
Jeff Bennett, CEO of Higi. “As more people postpone non-essential
medical appointments due to COVID, our stations are becoming
increasingly critical to their ability to track and monitor key
health indicators and access the health resources that are
available to them during this time. The OptimizeRx platform adds a
new, powerful tool that can help our users start and stay on
prescribed therapies to help them improve their health.”
Miriam Paramore, president of OptimizeRx, commented: “Our
mission has always been about making healthcare more accessible to
more patients by improving affordability and supporting adherence
to prescribed treatment plans. Working with Higi allows us to put
more control directly into the hands of patients and raises
awareness of the support available to them outside the care
setting.
“The partnership between Higi and OptimizeRx represents a great
initial step for our strategy to reach patients directly. We see
this expanded reach of our platform building a meaningful revenue
opportunity for us as well as our point-of-dispense partners over
time, as we continue to grow beyond our point-of-care reach.”
The new offering is free-of-charge to patients, while providing
a new point-of-engagement for OptimizeRx digital health platform
clients. Higi Smart Station users complete more than 3.7 million
body measurement tests per month on average, which presents
significant ‘foot traffic’ for OptimizeRx platform clients. To
date, more than 62 million people have used a Higi Station to
perform over 372 million biometric tests.
About HigiHigi is a consumer health engagement
company making it easier for all people to measure, track and act
on their health data by bridging physical and digital touch points
of the healthcare ecosystem. In service of health systems, health
plans, retailers and consumer healthcare brands, Higi’s
omni-channel platform meets consumers in their communities, at home
and on the go. Partners connect with the consumers they care for
through our nationwide network of 10,000 FDA-cleared, free-to-use
self-screening Smart Health Stations, home health devices, digital
and mobile tools. Our platform drives engagement through
out-of-the-box assessments, cohort-driven programs and
configurable, partner-branded health surveys that identify health
risks and needs and inform our digital referral engine to match and
connect consumers with the appropriate partner programs. With the
ability to move this data into healthcare’s workflows, Higi
delivers digital health engagement at scale, creating actionable
connections to the healthcare organizations that provide care and
support through personalized healthcare journeys. To date, more
than 62 million people have used a Higi Station to conduct over 372
million biometric tests.
For more information, visit us at www.higi.com.
About OptimizeRxOptimizeRx Corporation (NASDAQ:
OPRX) is a digital health company that facilitates communication at
point-of-care among all stakeholders in healthcare. Primarily
focused on life science and payer clients, its suite of digital and
mobile SaaS-based solutions enables affordability, patient
adherence and care management. OptimizeRx’s network reaches more
than 60% of U.S. ambulatory providers, delivering therapeutic
support on specialty medications and patient financial assistance
directly within a provider’s workflow through leading electronic
health platforms. OptimizeRx’s fully integrated platform supports
the real-time exchange of information, improving provider knowledge
and patient engagement, and ultimately leading to healthier
outcomes.
For more information, follow the company
on Twitter, LinkedIn or
visit www.optimizerx.com.
Important Cautions Regarding Forward Looking
StatementsThis press release contains forward-looking
statements within the definition of Section 27A of the Securities
Act of 1933, as amended, and such as in section 21E of the
Securities Act of 1934, as amended. These forward-looking
statements should not be used to make an investment decision. The
words 'estimate,' 'possible' and 'seeking' and similar expressions
identify forward-looking statements, which speak only as to the
date the statement was made. The company undertakes no obligation
to publicly update or revise any forward-looking statements,
whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect
of government regulation, competition and other material
risks.
OptimizeRx Contact Doug
Baker, CFOTel (248) 651-6568 (x807)dbaker@optimizerx.com
Media Relations Contact Maira Alejandra,
Media Relations ManagerTel (754) 245-7070
malejandra@optimizerx.com
Investor Relations Contact Ron Both,
CMA Tel (949) 432-7557 oprx@cma.team
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024